Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... ultrasound examination and the assessment of the patients' clinical features for differentiating HBL from HCC in children.

Background and Aim: Hepatocellular carcinoma (HCC) is the third most common reason for cancer-related death worldwide. Many countries either lack appropriate clinical practice guidelines for the ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

To address this critical clinical gap, the research team developed ... Spatial immune scoring system predicts hepatocellular ...

Bayer announced initiation of a phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to treat tumours expressing Glypican-3 (GPC3 ...